Response by Prysyazhna et al to Letter Regarding Article, "Blood Pressure-Lowering by the Antioxidant Resveratrol Is Counterintuitively Mediated by Oxidation of cGMP-Dependent Protein Kinase"

Circulation. 2019 Nov 26;140(22):e810-e811. doi: 10.1161/CIRCULATIONAHA.119.043869. Epub 2019 Nov 25.

Authors

Oleksandra Prysyazhna¹, Kathryn Wolhuter¹, Christopher Switzer¹, Celio Santos², Xiaoping Yang³, Steven Lynham³, Ajay M Shah², Philip Eaton¹, Joseph R Burgoyne¹

Affiliations

¹ School of Cardiovascular Medicine & Sciences, The British Heart Foundation Centre of Excellence, St Thomas' Hospital, The Rayne Institute (O.P, K.W., C.S., P.E, J.R.B.),, King's College London, United Kingdom.
² The James Black Centre (C.S., A.M.S.), King's College London, United Kingdom.
³ Centre of Excellence for Mass Spectrometry, Proteomics Facility, The James Black Centre (X.Y., S.L.), King's College London, United Kingdom.

PMID: 31765257
DOI: 10.1161/CIRCULATIONAHA.119.043869

No abstract available

Publication types

Letter
Kommentar

MeSH terms

Antioxidants*
Blood Pressure
Blood Pressure Determination
Cyclic GMP-Dependent Protein Kinases
Resveratrol*

Substances

Antioxidants
Cyclic GMP-Dependent Protein Kinases
Resveratrol

Grants and funding